14 December 2022

Safety alerts for pharmaceutical products and medical devices

Reference: CIR-2022-00000248

To all Health facilities / all health care practitioners in Dubai's private health sector

Referring to the above subject, DHA notifies all health facilities regarding the circular issued by the MOHAP for perusal and adhere to what is stated

 

Urgent Field Safety Notice Catheter Repair Kits (Various)

Medical Product Lot Recall Nasehaler (Mometasone Furoate Nasal Spray 50 mcg)

Recall One lot of Medical Device Accu-Chek Solo cannula assembly & pump holder (6 mm; 10+3)

Urgent Field Safety Notice Angiographic Catheter Extensions

Drug Safety Communication- Prolia (denosumab)- Risk of Severe Hypocalcemia in Patients on Dialysis

Lifting the Recall of pharmaceutical product Antrolin Cream

Field Safety Notice Prefilled Glass Syringes and Certain Luer-Activated Valve (LAV) Connectors

Medical Device Recall WatchCare Incontinence Management System (IMS)

Alert Against the use of Counterfeit version of medicinal product DefitelioTM (defibrotide) 80 mg/mL concentrate for solution for infusion

Notification on Counterfeit RETEVMO 80mg, pack of 60 Capsules

Field Safety Notice Percept™ PC Implantable Neurostimulator (INS) Model B35200

 

Thanks in advance for your good co-operation

 

Drug Control Section

Health Regulation Sector

DHA

Supporting Documents:

تقارير السلامة للوسائل الطبية - Catheter Repair Kits-1.pdf:

View Document

سحب تشغيلة واحدة من المستحضر الطبي Nasehaler- 1.pdf:

View Document

سحب تشغيلة من وسيلة طبية Accu-Chek Solo cannula assembly pump holder-1.pdf:

View Document

تقارير السلامة للوسائل الطبية - Angiographic Catheter Extensions-1.pdf:

View Document

تعميم اداري 8973-2022 تحذير Prolia.pdf:

View Document

تعميم اداري 8974-2022-رفع سحب منتج طبي - Antrolin Cream-9066.pdf:

View Document

تقارير السلامة للوسائل الطبية - Prefilled Glass Syringes-9067.pdf:

View Document

تقارير السلامة للوسائل الطبية - WatchCare Incontinice Managment System-9069.pdf:

View Document

DefitelioTM (defibrotide) 80 mg-mL تحذير من استخدام_.pdf:

View Document

تحذير من استخدام المنتج - RETEVMO 80 mg pack of 60 Capsules -----.pdf:

View Document

تقارير السلامة للوسائل الطبية - Percept PC Implantable Neurostimulator (INS) ---.pdf:

View Document